What are the key takeaways for Chicago Atlantic BDC Inc ($LIEN)?

Highest-attention: Significant debt expansion was executed in Q1 2026, with outstanding debt jumping from $25.00 million to $54.50 million to fund a highly active loan origination pipeline. Portfolio Expansion Momentum: Revenue rose 40.1% YoY to $16.70 million, showing strong loan deployment capabilities in underserved middle-market credit sectors. Negative Free Cash Flow from Deployment: The company reported a negative free cash flow of -$20.83 million in Q1 2026, reflecting the rapid deployment of capital into portfolio investments rather than operational distress.

Chicago Atlantic BDC Inc (LIEN) AI Stock Analysis & Earnings

Please enable JavaScript to continue using this application.

Latest Report Overview for Chicago Atlantic BDC Inc ($LIEN)

AI-powered analysis of Chicago Atlantic BDC Inc (LIEN) stock based on Q1 2026 financial data.

Published: July 16, 2026

Latest Report Overview

Chicago Atlantic BDC Inc (LIEN) reported For the quarterly period ended March 31, 2026 (Issuer fiscal Q1 2026) total investment income of $16.70 million, representing a 40.1% increase year-over-year, alongside net income of $8.54 million and diluted earnings per share of $0.37. This top-line momentum was driven by robust lending originations, though aggressive capital deployment into new senior secured loans generated a negative free cash flow of -$20.83 million. The company's rapid credit deployment during the quarter was financed primarily through revolving credit facility drawdowns. Outstanding debt obligations escalated to $54.50 million, up from $25.00 million as of December 31, 2025, illustrating a rapid utilization of available leverage to secure high-yielding commercial assets. Concurrently, cash reserves declined to $3.35 million, representing a tight liquid runway that heightens LIEN's reliance on continuous borrowing capacity expansion or secondary market capital raises. Portfolio credit quality remained highly stable, with no new borrowers placed on non-accrual status during the quarter. Management continues to prioritize senior secured first-lien structures backed by substantial hard collateral, such as real estate, equipment, and licensed facility assets. The company remains uniquely positioned to capture attractive yield premiums in the state-licensed cannabis lending market due to persistent federal restrictions that exclude traditional institutional banking competition.

Key Takeaways for Chicago Atlantic BDC Inc

Highest-attention: Significant debt expansion was executed in Q1 2026, with outstanding debt jumping from $25.00 million to $54.50 million to fund a highly active loan origination pipeline.
Portfolio Expansion Momentum: Revenue rose 40.1% YoY to $16.70 million, showing strong loan deployment capabilities in underserved middle-market credit sectors.
Negative Free Cash Flow from Deployment: The company reported a negative free cash flow of -$20.83 million in Q1 2026, reflecting the rapid deployment of capital into portfolio investments rather than operational distress.
Resilient Bottom-Line Margin: Net income reached $8.54 million with a diluted EPS of $0.37, sustaining a solid 51.1% net profit margin despite rising interest expenses.
Dwindling Cash Cushion: Cash and cash equivalents decreased to $3.35 million from $14.92 million in the prior year, highlighting a growing dependence on debt draws or equity issuance for near-term originations.
Evolving Federal Catalyst: Federal administrative steps toward rescheduling cannabis to Schedule III represent a major macro catalyst that could improve borrower credit but also invite future banking competition.

What Does Chicago Atlantic BDC Inc Do?

Chicago Atlantic BDC Inc (LIEN) is an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940. The company's primary investment objective is to generate current income and, to a lesser extent, capital appreciation, primarily through senior secured loans (including first-lien loans) to middle-market companies. LIEN is managed by Chicago Atlantic BDC Advisers, LLC, which leverages its specialized sourcing, underwriting, and portfolio management platform. The company primarily targets borrowers in highly regulated or federally restricted industries, with a significant portion of its credit portfolio allocated to state-licensed cannabis operators. Because cannabis remains classified as a Schedule I controlled substance under federal law, traditional commercial banks are largely barred from providing financing, leaving operators highly underserved. This credit supply shortage allows LIEN to step in as a premier capital partner, structuring customized debt agreements with attractive terms and robust collateral packages. With a trailing twelve-month (TTM) revenue of approximately $59.08 million and total debt outstanding of $54.50 million as of March 31, 2026, LIEN operates as a nimble commercial lender. The company's market capitalization stands at approximately $226.15 million. To mitigate borrower default risks, LIEN focuses on securing first-lien positions on physical assets, real estate, equipment, intellectual property, and state licenses, ensuring substantial downside protection on its investments.

Growth Drivers for Chicago Atlantic BDC Inc

Credit Supply-Demand Imbalance: Ongoing traditional bank exclusion from the cannabis sector allows LIEN to capture strong demand for professional credit at premium interest rates.
Floating-Rate Loan Structure: Linking loan portfolios to floating benchmarks (such as SOFR) captures higher interest income while utilizing interest floors to protect against downside rate cuts.
Debt Facility Utilization: Drawing down on revolving credit facilities, which expanded to $54.50 million in Q1 2026, actively expands interest-earning assets.
Upfront Origination Fees: Collecting upfront fees ranging from 1-3% of newly originated loan principals boosts near-term revenue during peak deployment quarters.
Evolving Legalization Frontiers: Newly approved state cannabis markets create a constant pipeline of operators needing construction, expansion, and acquisition financing.

Overview AI Summary Charts Financials Valuation

Based on March 31, 2026

Latest Report Overview for Chicago Atlantic BDC Inc ($LIEN)

Key Takeaways

1.Highest-attention: Significant debt expansion was executed in Q1 2026, with outstanding debt jumping from $25.00 million to $54.50 million to fund a highly active loan origination pipeline.
2.Portfolio Expansion Momentum: Revenue rose 40.1% YoY to $16.70 million, showing strong loan deployment capabilities in underserved middle-market credit sectors.
3.Negative Free Cash Flow from Deployment: The company reported a negative free cash flow of -$20.83 million in Q1 2026, reflecting the rapid deployment of capital into portfolio investments rather than operational distress.
4.Resilient Bottom-Line Margin: Net income reached $8.54 million with a diluted EPS of $0.37, sustaining a solid 51.1% net profit margin despite rising interest expenses.
5.Dwindling Cash Cushion: Cash and cash equivalents decreased to $3.35 million from $14.92 million in the prior year, highlighting a growing dependence on debt draws or equity issuance for near-term originations.
6.Evolving Federal Catalyst: Federal administrative steps toward rescheduling cannabis to Schedule III represent a major macro catalyst that could improve borrower credit but also invite future banking competition.

What They Do

How They Make Money

LIEN's revenue model is driven primarily by interest income generated from its specialized debt investment portfolio, alongside fee income consisting of origination, amendment, prepayment, and syndication fees. The company recognizes interest income on an accrual basis, provided that the borrower is performing and collection of interest is considered probable. Upfront loan origination fees are typically deferred and amortized over the life of the loan as an adjustment to the yield using the effective interest method. Due to the contractually structured nature of its commercial loan book, LIEN's revenue is highly recurring, with monthly or quarterly interest payments constituting over 70% of total revenue. Growth in revenue is propelled by the volume of new loan originations, the absolute size of its par-value portfolio, and floating-rate yields typically tied to benchmark rates like SOFR, which often incorporate contractual interest floors. Front-end fees provide minor one-time spikes during quarters with high origination volumes. Conversely, revenue can contract if borrowers experience severe financial stress and are placed on non-accrual status, halting interest income recognition. To maintain its tax-advantaged status as a Registered Investment Company (RIC) under Subchapter M of the Internal Revenue Code, LIEN must distribute at least 90% of its investment company taxable income to shareholders annually, preventing the retention of earnings and rendering the company dependent on external debt and equity markets to fund strategic portfolio expansion.

Competitive Position

LIEN operates in the highly competitive BDC and private credit markets, but carves out a highly specialized niche by targeting state-licensed cannabis operators and related companies. Its primary competitors include other cannabis-focused specialty lenders such as Chicago Atlantic Real Estate Finance (REFI), AFC Gamma (AFCG), and Silver Spike Investment Corp (SSIC), as well as generalist middle-market BDCs and private credit funds. LIEN's competitive edge rests on its deep regulatory underwriting expertise, customized credit structures, and strong industry relationships managed by its investment Adviser. The company's competitive moat is strongly defended by federal regulatory barriers. Because the Controlled Substances Act prevents mainstream banks and institutional debt platforms from entering the cannabis sector, LIEN operates in an environment with high barriers to entry, enabling it to negotiate exceptional yields (typically 12% to 15%) and protective covenants. This pricing power is reflected in its high gross margins of 71-74% and net margins of over 50%, comparing favorably to typical financial sector peers. However, LIEN's competitive position remains structurally vulnerable to regulatory normalization. Federal legalization or the passage of banking reform laws could trigger a massive influx of traditional institutional capital, leading to severe yield compression and eroding LIEN's primary competitive advantage. Currently, the company's relative valuation context—characterized by a low P/E of 6.6 and a P/B of 0.7—suggests that the market is discounting its shares to reflect these long-term structural and credit risks.

Business Strategy & Moat

LIEN's business strategy centers on capital preservation and income maximization through disciplined senior secured lending to middle-market businesses in highly regulated sectors. Its moat is structurally derived from federal cannabis prohibitions and specialized underwriting systems, rather than network effects or customer switching costs. By focusing on borrowers with highly restricted capital options, LIEN secures conservative loan-to-value ratios, parent-level corporate guarantees, and expansive collateral coverage on borrowers' operational and physical assets. The capital allocation strategy is geared toward leveraging its balance sheet up to prudent limits to fund high-yielding debt opportunities. This is evidenced by the rapid expansion of outstanding debt to $54.50 million in Q1 2026. Because BDCs are required to pay out almost all taxable income to shareholders, the company's flywheel depends on its ability to access external capital markets. LIEN aims to issue debt and occasionally raise equity when shares trade at a premium to NAV, utilizing those proceeds to scale the loan book and improve operating efficiencies. The long-term durability of the moat depends on maintaining excellent credit quality. While current margins are exceptionally strong, BDCs can experience rapid deterioration if single large borrowers default. Because borrowers face zero switching costs and can easily refinance cheaper loans if alternative capital becomes available, LIEN's advisory team relies on continuous market sourcing and proactive portfolio monitoring to replace maturing credit and maintain its high-yield asset base.

Industry Outlook

The specialty finance and BDC industries are heavily influenced by the prevailing interest rate environment and credit conditions. For specialized lenders like LIEN, the state-licensed cannabis market acts as the dominant variable. While state-level cannabis markets are growing rapidly, federally prohibited operators face extreme capital shortages, maintaining high demand for non-traditional private credit. A primary tailwind for the industry is the potential rescheduling of cannabis from Schedule I to Schedule III of the Controlled Substances Act. This regulatory shift would eliminate the burdensome Internal Revenue Code Section 280E tax provision for cannabis businesses, immediately enhancing borrower cash flows, profitability, and credit quality. While this reduces default risks for LIEN, it could also trigger a major headwind by easing the path for mainstream commercial bank entry, resulting in competitive yield compression. From a macroeconomic perspective, BDCs benefit from elevated interest rates due to floating-rate loan structures, though prolonged rates place pressure on borrower debt service capacities. Conversely, if interest rates fall, LIEN's interest income will decline, though this would likely be partially offset by healthier borrower credit metrics and lower default rates. The industry remains in a regulatory transition, balancing immediate high-yield credit demands against the eventual normalization of federal drug policies.

Growth Drivers

•Credit Supply-Demand Imbalance: Ongoing traditional bank exclusion from the cannabis sector allows LIEN to capture strong demand for professional credit at premium interest rates.
•Floating-Rate Loan Structure: Linking loan portfolios to floating benchmarks (such as SOFR) captures higher interest income while utilizing interest floors to protect against downside rate cuts.
•Debt Facility Utilization: Drawing down on revolving credit facilities, which expanded to $54.50 million in Q1 2026, actively expands interest-earning assets.
•Upfront Origination Fees: Collecting upfront fees ranging from 1-3% of newly originated loan principals boosts near-term revenue during peak deployment quarters.
•Evolving Legalization Frontiers: Newly approved state cannabis markets create a constant pipeline of operators needing construction, expansion, and acquisition financing.

Recent Developments

•Debt Drawdown of $29.5 Million: During Q1 2026, outstanding debt obligations were expanded to $54.50 million, up from $25.00 million on December 31, 2025, to fund credit originations.
•Substantial Loan Funding: The company reported an outflow of -$20.83 million in operating and free cash flow in Q1 2026, driven by active credit originations.
•Federal Rescheduling Movement: Federal progress in early 2026 toward reclassifying cannabis to Schedule III improved broader market sentiment and expected borrower cash flows.
•Credit Base Amendments: Throughout the first quarter of 2026, the company adjusted its credit agreements to optimize liquidity and expand its borrowing potential.
•Stable Credit Metrics: Credit performance remained stable through the period ended March 31, 2026, with no major new non-accruals or defaults reported.

Catalysts

•Final DEA Schedule III Rescheduling Decision: A formal decision to reschedule cannabis would instantly reduce borrower tax rates and default risks, supporting portfolio quality.
•Federal Reserve Benchmark Rate Cuts: A significant shift toward interest rate reductions would directly compress yields on LIEN's floating-rate loans, lowering investment income.
•Credit Facility Expansion or Refinancing: Securing an expanded or lower-cost borrowing base would improve LIEN's liquidity and support future originations.
•Significant Portfolio Non-Accruals: Any announcement of a major borrower entering default or non-accrual status would place downside pressure on NAV and the stock price.
•Secondary Equity Offerings: Issuing new common stock to raise lending capital could dilute existing shareholder metrics if priced below net asset value (NAV).

RPO & Key Performance Indicators

•Lending Portfolio Yields: Outstanding debt investments continue to generate premium weighted average yields of 12-15%, reflecting strong pricing power in the specialized sector.
•Net Asset Value (NAV) Per Share: NAV per share remained stable, supported by solid net investment income that fully covers dividend payout requirements.
•Asset Coverage Capacity: The company maintained an asset coverage ratio well above the regulatory 150% threshold, ensuring extensive compliance margin.
•Minimal Non-Accrual Metrics: Non-accruals remained low as of March 31, 2026, highlighting strong underwriting discipline on highly structured commercial loans.

Strengths

•Exceptional Net Margin Performance: LIEN achieved a net margin of 51.1% in Q1 2026, highlighting highly profitable lending operations and low overhead costs.
•Protected Lending Niche: Traditional bank exclusion from the cannabis industry protects LIEN's high-yield senior loans from aggressive price competition.
•First-Lien Senior Secured Collateral: Focus on securing first-lien positions on hard assets (real estate, equipment, licenses) minimizes permanent loss-of-capital risks.
•Strong Return on Equity: A trailing twelve-month (TTM) ROE of 11.2% compares favorably to broader financial sector peers and demonstrates healthy capital efficiency.
•High Interest Coverage Ratio: With interest coverage at 24.80x, LIEN easily services its leverage costs, ensuring strong credit stability.
•Excellent Asset Quality: Minimal historical non-accruals underscore the efficacy of the Adviser's specialized underwriting standards.

Risks & Concerns for Chicago Atlantic BDC Inc ($LIEN)

You're one step away

Unlock the full risk analysis

See business risks, AI filing insights, and deeper research for this stock. Create a free account to continue — includes a 14-day Pro trial.

No card required • Free plan stays after trial

About this summary

AI-generated research for Chicago Atlantic BDC Inc (LIEN, filings period ending March 31, 2026). AI summaries, reports, and scoring can be inaccurate or incorrect; accuracy and correctness are not guaranteed. Informational only; not investment advice or personalized guidance.Enumerated risk factors in this view may be abbreviated for anonymous or guest sessions. Full risk sections are available with full access.

Summary generated on Jul 16, 2026.

Peers of Chicago Atlantic BDC Inc (LIEN)

HRZNAnalyse

Based on March 31, 2026

Latest Report Overview for Chicago Atlantic BDC Inc ($LIEN)

Key Takeaways

1.Highest-attention: Significant debt expansion was executed in Q1 2026, with outstanding debt jumping from $25.00 million to $54.50 million to fund a highly active loan origination pipeline.
2.Portfolio Expansion Momentum: Revenue rose 40.1% YoY to $16.70 million, showing strong loan deployment capabilities in underserved middle-market credit sectors.
3.Negative Free Cash Flow from Deployment: The company reported a negative free cash flow of -$20.83 million in Q1 2026, reflecting the rapid deployment of capital into portfolio investments rather than operational distress.
4.Resilient Bottom-Line Margin: Net income reached $8.54 million with a diluted EPS of $0.37, sustaining a solid 51.1% net profit margin despite rising interest expenses.
5.Dwindling Cash Cushion: Cash and cash equivalents decreased to $3.35 million from $14.92 million in the prior year, highlighting a growing dependence on debt draws or equity issuance for near-term originations.
6.Evolving Federal Catalyst: Federal administrative steps toward rescheduling cannabis to Schedule III represent a major macro catalyst that could improve borrower credit but also invite future banking competition.

What They Do

How They Make Money

Competitive Position

Business Strategy & Moat

Industry Outlook

Growth Drivers

•Credit Supply-Demand Imbalance: Ongoing traditional bank exclusion from the cannabis sector allows LIEN to capture strong demand for professional credit at premium interest rates.
•Floating-Rate Loan Structure: Linking loan portfolios to floating benchmarks (such as SOFR) captures higher interest income while utilizing interest floors to protect against downside rate cuts.
•Debt Facility Utilization: Drawing down on revolving credit facilities, which expanded to $54.50 million in Q1 2026, actively expands interest-earning assets.
•Upfront Origination Fees: Collecting upfront fees ranging from 1-3% of newly originated loan principals boosts near-term revenue during peak deployment quarters.
•Evolving Legalization Frontiers: Newly approved state cannabis markets create a constant pipeline of operators needing construction, expansion, and acquisition financing.

Recent Developments

•Debt Drawdown of $29.5 Million: During Q1 2026, outstanding debt obligations were expanded to $54.50 million, up from $25.00 million on December 31, 2025, to fund credit originations.
•Substantial Loan Funding: The company reported an outflow of -$20.83 million in operating and free cash flow in Q1 2026, driven by active credit originations.
•Federal Rescheduling Movement: Federal progress in early 2026 toward reclassifying cannabis to Schedule III improved broader market sentiment and expected borrower cash flows.
•Credit Base Amendments: Throughout the first quarter of 2026, the company adjusted its credit agreements to optimize liquidity and expand its borrowing potential.
•Stable Credit Metrics: Credit performance remained stable through the period ended March 31, 2026, with no major new non-accruals or defaults reported.

Catalysts

•Final DEA Schedule III Rescheduling Decision: A formal decision to reschedule cannabis would instantly reduce borrower tax rates and default risks, supporting portfolio quality.
•Federal Reserve Benchmark Rate Cuts: A significant shift toward interest rate reductions would directly compress yields on LIEN's floating-rate loans, lowering investment income.
•Credit Facility Expansion or Refinancing: Securing an expanded or lower-cost borrowing base would improve LIEN's liquidity and support future originations.
•Significant Portfolio Non-Accruals: Any announcement of a major borrower entering default or non-accrual status would place downside pressure on NAV and the stock price.
•Secondary Equity Offerings: Issuing new common stock to raise lending capital could dilute existing shareholder metrics if priced below net asset value (NAV).

RPO & Key Performance Indicators

•Lending Portfolio Yields: Outstanding debt investments continue to generate premium weighted average yields of 12-15%, reflecting strong pricing power in the specialized sector.
•Net Asset Value (NAV) Per Share: NAV per share remained stable, supported by solid net investment income that fully covers dividend payout requirements.
•Asset Coverage Capacity: The company maintained an asset coverage ratio well above the regulatory 150% threshold, ensuring extensive compliance margin.
•Minimal Non-Accrual Metrics: Non-accruals remained low as of March 31, 2026, highlighting strong underwriting discipline on highly structured commercial loans.

Strengths

•Exceptional Net Margin Performance: LIEN achieved a net margin of 51.1% in Q1 2026, highlighting highly profitable lending operations and low overhead costs.
•Protected Lending Niche: Traditional bank exclusion from the cannabis industry protects LIEN's high-yield senior loans from aggressive price competition.
•First-Lien Senior Secured Collateral: Focus on securing first-lien positions on hard assets (real estate, equipment, licenses) minimizes permanent loss-of-capital risks.
•Strong Return on Equity: A trailing twelve-month (TTM) ROE of 11.2% compares favorably to broader financial sector peers and demonstrates healthy capital efficiency.
•High Interest Coverage Ratio: With interest coverage at 24.80x, LIEN easily services its leverage costs, ensuring strong credit stability.
•Excellent Asset Quality: Minimal historical non-accruals underscore the efficacy of the Adviser's specialized underwriting standards.

Risks & Concerns for Chicago Atlantic BDC Inc ($LIEN)

You're one step away

Unlock the full risk analysis

See business risks, AI filing insights, and deeper research for this stock. Create a free account to continue — includes a 14-day Pro trial.

No card required • Free plan stays after trial

About this summary

Summary generated on Jul 16, 2026.

Latest Report Overview for Chicago Atlantic BDC Inc ($LIEN)

AI-powered analysis of Chicago Atlantic BDC Inc (LIEN) stock based on Q1 2026 financial data.

Published: July 16, 2026

Latest Report Overview

Key Takeaways for Chicago Atlantic BDC Inc

Highest-attention: Significant debt expansion was executed in Q1 2026, with outstanding debt jumping from $25.00 million to $54.50 million to fund a highly active loan origination pipeline.
Portfolio Expansion Momentum: Revenue rose 40.1% YoY to $16.70 million, showing strong loan deployment capabilities in underserved middle-market credit sectors.
Negative Free Cash Flow from Deployment: The company reported a negative free cash flow of -$20.83 million in Q1 2026, reflecting the rapid deployment of capital into portfolio investments rather than operational distress.
Resilient Bottom-Line Margin: Net income reached $8.54 million with a diluted EPS of $0.37, sustaining a solid 51.1% net profit margin despite rising interest expenses.
Dwindling Cash Cushion: Cash and cash equivalents decreased to $3.35 million from $14.92 million in the prior year, highlighting a growing dependence on debt draws or equity issuance for near-term originations.
Evolving Federal Catalyst: Federal administrative steps toward rescheduling cannabis to Schedule III represent a major macro catalyst that could improve borrower credit but also invite future banking competition.

What Does Chicago Atlantic BDC Inc Do?

Growth Drivers for Chicago Atlantic BDC Inc

Credit Supply-Demand Imbalance: Ongoing traditional bank exclusion from the cannabis sector allows LIEN to capture strong demand for professional credit at premium interest rates.
Floating-Rate Loan Structure: Linking loan portfolios to floating benchmarks (such as SOFR) captures higher interest income while utilizing interest floors to protect against downside rate cuts.
Debt Facility Utilization: Drawing down on revolving credit facilities, which expanded to $54.50 million in Q1 2026, actively expands interest-earning assets.
Upfront Origination Fees: Collecting upfront fees ranging from 1-3% of newly originated loan principals boosts near-term revenue during peak deployment quarters.
Evolving Legalization Frontiers: Newly approved state cannabis markets create a constant pipeline of operators needing construction, expansion, and acquisition financing.

Chicago Atlantic BDC Inc (LIEN) AI Stock Analysis & Earnings